ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 277 filers reported holding ROYALTY PHARMA PLC in Q1 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $222,440 | -21.0% | 8,196 | -10.5% | 0.00% | 0.0% |
| Q2 2023 | $281,640 | -66.8% | 9,162 | -61.1% | 0.00% | -50.0% |
| Q1 2023 | $848,903 | -60.5% | 23,561 | -56.7% | 0.00% | -66.7% |
| Q4 2022 | $2,150,994 | -49.5% | 54,428 | -48.7% | 0.01% | -57.1% |
| Q3 2022 | $4,263,000 | +34.1% | 106,103 | +40.2% | 0.01% | +40.0% |
| Q2 2022 | $3,179,000 | +150.1% | 75,653 | +131.9% | 0.01% | +233.3% |
| Q1 2022 | $1,271,000 | +505.2% | 32,626 | +518.0% | 0.00% | – |
| Q4 2021 | $210,000 | +9.9% | 5,279 | 0.0% | 0.00% | – |
| Q3 2021 | $191,000 | -11.6% | 5,279 | 0.0% | 0.00% | – |
| Q2 2021 | $216,000 | -6.5% | 5,279 | 0.0% | 0.00% | -100.0% |
| Q1 2021 | $231,000 | – | 5,279 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $294,957,000 | 88.74% |
| Vantage Consulting Group Inc | 8,705,551 | $379,735,000 | 76.23% |
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $116,930,000 | 72.07% |
| HARVARD MANAGEMENT CO INC | 10,714,284 | $467,357,000 | 26.11% |
| ROBERT WOOD JOHNSON FOUNDATION | 970,151 | $4,231,798,000 | 21.59% |
| Brown University | 381,759 | $16,652,000 | 11.44% |
| Overbrook Management Corp | 771,155 | $33,638,000 | 7.48% |
| SpiderRock Advisors, LLC | 778,800 | $34,236,000 | 4.79% |
| Renaissance Capital LLC | 452,948 | $19,758,000 | 2.93% |
| Lagoda Investment Management, L.P. | 104,835 | $4,573,000 | 2.28% |